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Although the innate branch of the immune 
system is poised to protect the host in response 
to injury or infection, its inappropriate activa-
tion often leads to pathologic accumulation of 
leukocytes in aff  ected organs. A diverse array 
of chemotactic signals is capable of recruiting 
leukocytes to sites of infl  ammation, including 
chemokines, bacterial peptides, proteolytic 
fragments of complement, and lipids. Of these 
mediators, leukotriene B4 (LTB4) is a highly 
potent lipid chemoattractant produced and re-
leased within minutes by neutrophils, macro-
phages, and mast cells, positioning it uniquely 
as a key element of the immediate infl  amma-
tory response (1). LTB4 binds with high speci-
fi  city and affi   nity to BLT1, a G protein–coupled 
seven transmembrane–spanning receptor (2, 3), 
which is highly expressed on neutrophils and 
induces their chemotaxis and adhesion in re-
sponse to LTB4 (4, 5). Within the infl  amed 
joints of patients with rheumatoid arthritis 
(RA), elevated levels of LTB4 correlate with 
disease severity (6) and synovial fl  uid leuko-
cytes highly express BLT1 (7), suggesting 
that this receptor–ligand pair contributes to 
the characteristic synovitis of RA by recruiting 
leukocytes into the infl  amed joint.
The K/BxN serum transfer model of in-
fl  ammatory arthritis bears certain clinical and 
histopathological similarities to human RA, in-
cluding abnormal leukocyte accumulation in 
synovial tissue and fl  uid, synovial hypertrophy 
and pannus formation, and erosion of bone and 
cartilage. Transfer of serum from K/BxN trans-
genic mice containing autoantibodies against 
glucose 6-phosphate isomerase results in a ro-
bust polyarthritis (8) that is dependent on the 
orchestrated participation of key eff  ectors  of 
innate immunity, as the FcγIII receptor, alter-
native complement pathway (9), and IL-1 (10) 
each play essential nonredundant roles in this 
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model. Innate immune cells are critically important, as mast 
cells (11) and neutrophils (12) are required for the generation 
of arthritis in this model. Although the identities and patho-
genetic importance of these leukocytes are now appreciated 
in this arthritis model, the specifi  c chemotactic signals that 
guide these cells into the infl  amed joint remain undefi  ned. 
In these studies, we aimed to characterize the role of BLT1 in 
this antibody-induced model of arthritis to identify potential 
therapeutic targets and to understand the complex dynamics 
of leukocyte recruitment into the joint.
RESULTS AND DISCUSSION
BLT1 is required for the generation 
of autoantibody-induced arthritis
Because BLT1 is a potent mediator of leukocyte chemotaxis 
in the immediate innate immune response, we tested whether 
mice lacking BLT1 would be capable of developing arthritis. 
Although age-matched C57BL/6 WT controls developed 
polyarthritis within days of K/BxN serum injection, BLT1−/− 
mice remained largely disease free by measurable clinical pa-
rameters (Fig. 1, a and b). When BLT1−/− mice developed 
any joint swelling or erythema, it was limited to one portion 
of one joint and resolved within a few days. Histological 
analysis corroborated our clinical fi  ndings (Fig. 1 c), as joints 
of WT arthritic mice demonstrated characteristic infl  amma-
tion, synovial hypertrophy, and joint erosions, fi  ndings that 
were absent or minimally present in BLT1−/− mice (Fig. 
1 d). Therefore, despite the existence of multiple redundant 
chemoattractant pathways active upon leukocytes, we found 
an absolute requirement for BLT1 in inducing joint infl  am-
mation and destruction in this arthritis model.
We examined the therapeutic potential of inhibiting 
BLT1 in this model using CP-105,696, a potent, specifi  c 
BLT1 antagonist that inhibits LTB4-induced neutrophil che-
motaxis (13), using two diff  erent dosing strategies. The pre-
ventative dosing group received CP-105,696 before the 
induction of arthritis and was protected from developing dis-
ease, displaying very minimal joint swelling soon after serum 
injection that quickly resolved (Fig. 2, a and b). The thera-
peutic dosing group received CP-105,696 during very active 
arthritis, which halted progression of disease and reversed 
  arthritis severity, although it did not remit completely (Fig. 2, a 
and b). Histological scoring demonstrated virtually no infl  am-
mation or bone and cartilage erosion when CP-105,696 was 
given preventatively and signifi  cant attenuation of these pa-
rameters when given therapeutically (Fig. 2 c). Additionally, 
although CP-105,696 eff  ectively decreased synovial hyper-
plasia, BLT1 inhibition dramatically suppressed synovial 
  neutrophil infi  ltration by 99.9 and 81.3% in the preventative 
and delayed treatment groups compared with the untreated 
group, indicating a primary role for BLT1 in recruiting 
  neutrophils into the joint (Fig. 2 d). Although delayed inhibi-
tion of BLT1 was capable of limiting ongoing arthritis, its eff  ec-
tiveness as a protective agent suggests that BLT1 plays an 
  important role in the early stages of disease. Protection by 
CP-105,696 in the K/BxN serum transfer model extends the 
therapeutic applicability of BLT1 antagonism, which also in-
hibited arthritis in a collagen-induced model (13).
BLT1 is necessary for synovial chemokine production 
in infl  ammatory arthritis
We next explored the mechanisms by which BLT1 may gen-
erate the appropriate signals for joint-specifi  c infl  ammation. 
A very early step in the initiation of arthritis in this model is 
the rapid deposition of arthritogenic anti–glucose 6-phos-
phate isomerase autoantibodies upon cartilaginous and syno-
vial surfaces of peripheral joints (8, 14), which is dependent 
on the presence of Fcγ receptor, neutrophils, and mast cells, 
but not the complement factor C5 (15). Although neutro-
phils have been shown to be necessary for joint-specifi  c 
  autoantibody localization (12), we found that both WT and 
BLT1−/− mice had similar levels of IgG lining the joint and 
cartilage surfaces, indicating that BLT1 does not play a role in 
Figure 1.  BLT1-defi  cient mice are resistant to K/BxN serum transfer 
arthritis. (a) Ankle thickness and (b) clinical score were determined in WT 
and BLT1−/− mice after injection of K/BxN serum (n = 5 each group). 
Data are representative of three independent experiments. (c) Representa-
tive histopathology of ankle joints from WT and BLT1−/− mice during 
early onset, early peak, and resolving disease activity. WT joints display 
synovial infl  ammation, cartilage, and bone erosions (fi  lled arrow), and 
synovial hypertrophy (asterisk), whereas BLT1−/− joints are free of infl  am-
mation and the synovium retains its relatively acellular composition (open 
arrows). Bar, 400 μm. (d) Histopathological scoring of ankles from WT and 
BLT1−/− mice during early onset, early peak, and resolving disease activity 
(n = 6–12 in each group). All error bars represent SEM. *, P < 0.001 
(WT vs. BLT1−/−).JEM VOL. 203, April 17, 2006  831
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the localization of arthritogenic antibody into the joint (Fig. 
3 a). The fact that mice lacking functional BLT1 develop an 
early mild arthritis that quickly resolves after K/BxN serum 
injection (Figs. 1, a and b, and 2, a and b) suggests that BLT1 
plays a critical role in inducing arthritis by amplifying the ini-
tial infl  ammatory response that follows arthritogenic antibody 
deposition within the joints.
To investigate the possibility that BLT1 mediates chemo-
kine and infl  ammatory cytokine production, thereby ampli-
fying subsequent infl  ammation, we measured their expression 
in the joints of WT and BLT1−/− mice using quantitative 
PCR (qPCR). In infl   amed WT arthritic joints, levels of 
RNA for chemokines mediating neutrophil chemotaxis were 
elevated, notably MIP-2/CXL2 as well as MIP-1α/CCL3 
and ENA-78/CXCL5, but not KC/CXCL1 (Fig. 3, b and c). 
Accordingly, levels of RNA for CXCR2 and CCR1, the 
primary murine neutrophil chemokine receptors, were ele-
vated in the WT synovial fl  uid as well as the C5a receptor 
(C5aR), which mediates phagocyte chemotaxis toward the 
complement anaphylatoxin C5a (Fig. 3, d and e). We also 
observed elevated levels of RNA for the monocyte-active 
chemokines MIP-1β/CCL4, RANTES/CCL5, and MCP5/
CCL12 in the WT arthritic joints (Fig. 3, b and c). Levels of 
RNA for CCR2 and CCR5, chemokine receptors com-
monly found on monocytes, were elevated in the infl  amed 
WT synovial fl  uid (Fig. 3, d and e), but levels of CXCR3, 
the primary T lymphocyte chemokine receptor, were not. 
Elevated CXCR4 in WT joint fl  uid likely represents in-
creased cellularity, as it is expressed on multiple cell lineages, 
and levels of SDF/CXCL12 were not signifi  cantly diff  erent 
in arthritic WT compared with BLT1−/− mice (not de-
picted). Levels of IL-1β, a critical cytokine in the progression 
of K/BxN serum transfer arthritis (10), were signifi  cantly el-
evated, whereas TNF-α expression was not, consistent with 
the previous fi   nding of this model’s variable dependence 
upon TNF-α (Fig. 3, b and c). Although levels of multiple 
chemokines, their receptors, and IL-1β were elevated in the 
joints of WT mice, levels of these infl  ammatory mediators in 
the joints of BLT1−/− mice were consistently lower or absent 
(Fig. 3, b–e), indicating that BLT1 is needed for subsequent 
Figure 2.  The BLT1 inhibitor CP-105,696 prevents and treats 
  arthritis. The specifi  c BLT1 inhibitor CP-105,696 was administered daily 
to C57BL/6 mice before the induction of disease on day −1 (preventative, 
fi  lled arrows) or as disease was approaching maximal activity on day 5 
(delayed, open arrows), and ankle thickness (a) and clinical score (b) were 
assessed daily (n = 4 in each group). Data are representative of three 
independent experiments. In a separate experiment, mice received sham 
gavage of vehicle lacking CP-105,696 without any effect on arthritis pro-
duction (not depicted). (c) Histopathological scoring of ankles from con-
trol untreated mice compared with mice treated with preventative or 
delayed CP-105,696 dosing strategies (n = 10–15 in each group). Error bars 
represent SEM. (d) Total number of synovial cells and neutrophils within 
the joints of control untreated mice and mice treated with preventative 
or delayed CP-105,696 dosing strategies. *, P ≤ 0.005; **, P < 0.0001 
(control vs. CP-105,696 treated).
Figure 3.  BLT1 is required for synovial infl  ammatory chemokine 
and cytokine production in infl  ammatory arthritis. (a) K/BxN serum 
was administered to WT and BLT1−/− mice, and ankles were harvested at 
7 d. Frozen ankle sections were stained with FITC-labeled F(ab′)2 fragment 
directed against the Fc portion of mouse IgG. A WT mouse that did not 
receive any serum was used as a control. Bar, 230 μm. (b–e) Chemokine 
expression was measured by qPCR of total RNA isolated from synovial 
tissue on postserum transfer days 3 (early onset disease) (b) or 7 (early 
active disease) (c). Chemokine receptor expression was quantifi  ed by qPCR 
of total RNA isolated from synovial fl  uid at days 3 (d) and 7 (e). Total RNA 
was extracted from eight individual ankles in each experimental group, 
and qPCR reactions were run separately on each sample. Error bars repre-
sent SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.0005 (WT vs. BLT1−/−).832  BLT1 IN INFLAMMATORY ARTHRITIS  | Kim et al.
chemokine- and IL-1–mediated joint infl  ammation in the 
K/BxN serum transfer model.
Neutrophil BLT1 directs leukocyte recruitment 
into the joint in a noncell-autonomous manner
Because neutrophils have been shown to be critical in in-
ducing arthritis in the K/BxN serum transfer model of ar-
thritis (12) and are present in high numbers in synovial fl  uid 
and at the cartilage–pannus junction in human RA, where 
they are capable of promoting signifi  cant joint infl  ammation 
and destruction (16), we wanted to determine whether the 
requirement for BLT1 is specifi  c to the neutrophil popula-
tion. Purifi  ed bone marrow neutrophils (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20052349/DC1) 
were adoptively transferred to BLT1−/− mice on the same 
days of K/BxN serum transfer (days 0 and 2). All BLT1−/− 
mice that received WT neutrophils via adoptive transfer 
(WT PMN→BLT1−/− mice) subsequently developed ar-
thritis (Fig. 4, a and b). Their disease course was nearly 
identical to the WT mice in the early stages, as disease was 
reaching maximal activity; however, the arthritis in WT 
PMN→BLT1−/− mice improved more rapidly than in the 
WT mice, completely resolving 1 wk earlier than the WT 
group. Synovial fl  uid analysis demonstrated similar numbers 
of neutrophils in both the WT and WT PMN→BLT1−/− 
mice at 20 h, but at 4 d, the number of synovial fl  uid neu-
trophils in the WT PMN→BLT1−/− mice was signifi  cantly 
lower (Fig. 4 c). Neutrophils have a short life span in the 
circulation of <24 h (17), so the attenuated disease course 
in the WT PMN→BLT1−/− mice demonstrates the re-
quirement for the persistence of BLT1-expressing neutro-
phils for sustained joint infl  ammation. BLT1−/− mice that 
received BLT1−/− neutrophils via adoptive transfer did not 
develop arthritis and did not have transferred or endogenous 
BLT1−/− neutrophils in their joints, confi  rming that the ef-
fect of the neutrophil adoptive transfer was dependent on 
neutrophil BLT1 expression (Fig. 4, a–c).
In the WT PMN→BLT1−/− mice that developed arthri-
tis, we examined whether BLT1-directed neutrophil traffi   ck-
ing into the synovial fl  uid was responsible for restoring joint 
infl  ammation. To do this, we transferred neutrophils from 
WT mice expressing the leukocyte antigen CD45.1+ to dis-
tinguish from host-derived BLT1−/− CD45.2+ neutrophils 
by fl  ow cytometry. Although one might have expected that 
the neutrophils in infl   amed joints would be primarily the 
transferred WT neutrophils expressing BLT1 given their abil-
ity to recapitulate arthritis, we found that the vast majority 
of the synovial fl  uid neutrophils during peak disease activity 
(4 d) were actually endogenous BLT1−/− neutrophils (mean 
93.4 ± 0.71% SEM) with very few transferred WT neutro-
phils (mean 6.6 ± 0.71% SEM; Fig. 4 d). When joint fl  uid 
was analyzed earlier at the initiation of clinical disease (20 h), 
transferred WT neutrophils constituted a greater proportion 
of total neutrophils (mean 38.66 ± 5.7% SEM; Fig. 4, d and e), 
indicating that the entry of a small number of WT neutrophils 
into the joint preceded the signifi  cant recruitment of BLT1−/− 
neutrophils into the joint during peak infl  ammation (Fig. 4 f). 
Levels of transferred WT neutrophils within the blood 
  remained low at both time points (Fig. 4, d and e), indicating 
that the increased percentage of WT neutrophils in the joint 
at the early time point was not a mere refl  ection of the levels 
of WT neutrophils in the peripheral blood.
Adoptive transfer of WT neutrophils restored the up-
regulation of infl  ammatory chemokines in the joint (Fig. 
4 g), thereby providing additional chemotactic signals for 
BLT1−/− neutrophils and other leukocytes to enter the joint 
and generate infl  ammatory arthritis. Interestingly, when ar-
thritis trailed off   in the WT PMN→BLT1−/− mice, synovial 
RNA levels of IL-1β and various chemokines, including 
those active on neutrophils such as ENA-78/CXCL5 and 
MIP-2/CXCL2, dropped off   between the two groups (Fig. 
4 f). These data suggest an ongoing requirement for BLT1 to 
maintain IL-1β and chemokine expression and subsequently 
recruit BLT1−/− neutrophils.
These experiments demonstrate that BLT1 expression by 
neutrophils is required for the development of infl  ammatory 
arthritis in the K/BxN serum transfer model by functioning 
in a non–cell-autonomous manner to allow the subsequent 
entry of neutrophils into the joint independently of BLT1. 
Furthermore, neutrophil BLT1 expression is required for 
the sustained production of IL-1β and multiple chemokines, 
which amplify the infl  ammatory response. Independent inves-
tigations have confi  rmed that neutrophils are also the primary 
source of synthesized LTB4 necessary for joint infl  ammation 
in this model, in addition to being the critical BLT1-express-
ing cell population (18). Collectively, these studies highlight 
the importance of an LTB4-BLT1 autocrine loop in confer-
ring these neutrophils with the crucial function of directing 
cellular recruitment into the joint in a non–cell-autonomous 
fashion. Although BLT1 antagonism has been shown to be 
eff  ective in inhibiting infl  ammation in another model of ar-
thritis (13), our studies now describe an important new mech-
anism by which BLT1 induces joint infl  ammation.
Chemokines and other chemoattractants have long been 
noted to possess redundant roles in directing the traffi   cking of 
similar cell populations. However, we have now established 
the absolute, nonredundant requirement for BLT1 in the 
K/BxN serum transfer model of arthritis, in spite of the nece-
ssity of the C5a receptor (9) and up-regulation of multiple 
chemokines in this model. Previous studies have demon-
strated that BLT1 activation can act synergistically with other 
chemoattractant receptors to promote leukocyte recruitment 
(19, 20). In this model, however, we have demonstrated that 
BLT1 works upstream of other chemoattractant receptors in 
a sequential manner as a mandatory event required for further 
leukocyte recruitment by other chemoattractants.
Upon activation, neutrophils release an array of pro-
infl  ammatory products, including newly synthesized reactive 
oxygen metabolites, cytokines, chemokines, and lipids, as well 
as preformed granular enzymes and proteins (16, 21), and 
LTB4 is known to be a potent neutrophil secretagogue (22). 
We hypothesize that specifi  c LTB4-induced BLT1 activation JEM VOL. 203, April 17, 2006  833
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Figure 4.  WT BLT1-expressing neutrophils are required for the 
generation of arthritis by promoting entry of BLT1−/− neutrophils 
into the joint. Bone marrow neutrophils from WT and BLT1−/− mice 
were adoptively transferred to BLT1−/− mice on days 0 and 2, and (a) 
ankle thickness and (b) clinical score were assessed daily. n = 3–4 in each 
group, and data are representative of three independent experiments. 
(c) Total numbers of Gr-1+ neutrophils within the ankle synovial fl  uid of WT 
mice, BLT1−/− mice that received WT neutrophils (WT PMN→BLT1−/−), 
BLT1−/− mice, and BLT1−/− mice that received BLT1−/− neutrophils 
(BLT1−/− PMN→BLT1−/−) at 20 h and 4 d. (d) Representative fl  ow cyto-
metric analysis of Gr-1+ neutrophils in the blood and ankle synovial fl  uid 
from WT PMN→BLT1−/− mice at 20 h and 4 d after initial serum and 
neutrophil transfer. For these experiments, transferred CD45.1+ WT neutro-
phils were used to distinguish from endogenous CD45.2+ BLT1−/− neutrophils. 
For comparison, synovial fl  uid analysis from WT mice is depicted in Fig. S2. 
(e) Percentage of transferred Gr-1+ WT neutrophils out of total neutrophils in the 
blood and synovial fl  uid of WT PMN→BLT1−/− mice at 20 h and 4 d. (f) Total 
numbers of transferred WT and endogenous BLT1−/− neutrophils within the 
synovial fl  uid of WT PMN→BLT1−/− mice at 20 h and 4 d. (g and h) Ankle syno-
vial tissue was harvested, and total RNA was isolated from WT PMN→BLT1−/− 
mice at 3 (g) and 12 (h) d after initial serum and adoptive neutrophil transfer. 
Chemokine expression was measured by qPCR. RNA from six to eight individual 
ankles was isolated. Error bars represent SEM. *, P < 0.05; **, P < 0.005 (WT vs. 
WT PMN→BLT1−/− mice).834  BLT1 IN INFLAMMATORY ARTHRITIS  | Kim et al.
of neutrophils initiates a unique pathway that generates 
  specifi  c proinfl  ammatory mediators that are required for leuko-
cytes to subsequently migrate into sites of infl  ammation. 
  Although the precise mechanisms by which this process oc-
curs remain to be elucidated, our fi  ndings describe a novel 
and previously unrecognized important biological role for 
BLT1 in directing neutrophil recruitment in a non–cell-
  autonomous manner, revealing yet another facet of the intri-
cate biology of leukocyte traffi   cking.
MATERIALS AND METHODS
Mice. KRN mice were provided by D. Mathis and C. Benoist (Harvard Med-
ical School, Boston, MA). K/BxN mice were obtained by crossing KRN with 
NOD/LtJ mice (The Jackson Laboratory). BLT1-defi  cient mice were gener-
ated in our laboratory (4). B6.SJL-PtprcaPep3b/BoyJ (CD45.1+) and C57BL/6 
mice were from The Jackson Laboratory or the National Cancer Institute. All 
experiments were performed according to protocols approved by the Massa-
chusetts General Hospital Subcommittee on Research Animal Care.
Serum transfer and arthritis scoring. Pooled serum from 8-wk-old 
  arthritic K/BxN mice was injected into recipient mice (150 μl serum i.p. 
on days 0 and 2). Hind ankles were measured with a pocket thickness gage 
(Mitutoyo America), and the average was calculated. Clinical scoring for 
each paw was based on the following index: 0, no edema/erythema; 1, localized 
edema/erythema over one surface of paw; 2, edema/erythema involving the 
entirety of one surface of paw; 3, edema/erythema involving both surfaces 
of paw. Scores were added for all four paws for a composite score.
Histological scoring. Dissected ankles were fi  xed in 10% neutral buff  ered 
formalin and demineralized in modifi  ed Kristensen’s solution. Histological 
scoring of infl  ammation, cartilage erosion, and bone erosion were ranked as 
follows: 0, normal; 1, minimal; 2, mild; 3, moderate; 4, marked; 5, severe 
(23). To quantify synovial hyperplasia and neutrophil accumulation, total cell 
number was calculated by counting nuclei and total neutrophil numbers were 
calculated by counting cells with polymorphonuclear morphology within 
a 0.1-mm2 section of synovium.
RNA isolation. RNA was prepared using a modifi  cation of the LiCl/urea 
technique. Ankle synovial cavity contents were lavaged with PBS. Synovial 
surfaces were immersed in 6 M urea/2% SDS. The RNA solution was pre-
cipitated with 6 M urea/6M LiCl/20 mM NaOAc, resuspended with 
6 M urea/3M LiCl/20 mM NaOAc, proteinase K treated, and phenol-
  chloroform extracted.
qPCR. Total RNA was DNaseI (Invitrogen) treated. 10–50 ng total RNA 
was used as template for the RT reaction. 50 μl cDNA was synthesized 
using oligo(dT)15, random hexamers, and multiscribe reverse transcriptase 
(Applied Biosystems). All samples were reverse transcribed under the same 
conditions and from the same RT master mix to minimize diff  erences 
in RT effi   ciency. The qPCR reaction was performed with 5 μl cDNA, 
12.5 μl 2× SYBR green master mix (Stratagene), and 250 nmol sense and 
  antisense primer. All oligonucleotide primers for qPCR (Table S1, avail-
able at http://www.jem. org/cgi/content/full/jem.20052349/DC1) were 
from Invitrogen. Emitted fl  uorescence for each reaction was measured three 
times during the annealing/extension phase, and amplifi  cation plots were 
analyzed using MX4000 software version 3.0 (Stratagene). Quantity values 
for gene expression were generated by comparison of the fl  uorescence gen-
erated by each sample with standard curves of known quantities, and the 
calculated number of copies was divided by the number of copies of the 
housekeeping gene β2 microglobulin.
Administration of CP-105,696. CP-105,696 was provided by Pfi  zer. 
10 mg/kg CP-105,696 was administered via gavage in 10% EtOH, 0.5% 
methylcellulose, and 0.5% Tween 80.
Bone marrow neutrophil adoptive transfer. Marrow cavities of the tib-
ias and femurs of 8-wk-old donor mice were fl  ushed with DMEM 10% FCS 
media. After RBC hypotonic lysis, mature neutrophils were isolated by cen-
trifugation over discontinuous Percoll gradients at 500 g for 30 min at 28°C, 
consisting of 55 (vol/vol), 65 (vol/vol), and 75% (vol/vol) Percoll in PBS. 
Mature neutrophils recovered at the interface of the 65 and 75% fractions 
were >90% pure and >95% viable as determined by Wright-Giemsa stain-
ing and trypan blue exclusion, respectively. 5 × 106 neutrophils in HBSS 
were injected i.v. into 8-wk-old recipient mice. For the neutrophil transfer 
experiments, 150 μl K/BxN serum was injected i.v. on days 0 and 2.
Flow cytometry. Ankle joint synovial fl   uid was lavaged with 5 μl 
HBSS/5% FCS, and contents from both ankles were pooled for each mouse. 
Synovial fl  uid leukocytes were counted using a hemacytometer. Leukocytes 
were incubated with 2.4G2 anti-FcγIII/II receptor and stained with PE-
conjugated anti–mouse CD45.1, FITC-conjugated anti–mouse CD45.2, 
and APC-conjugated anti–mouse Gr-1 (BD Biosciences). Cytofl  uorimetry 
was performed with a FACSCalibur Cytometer (Becton Dickinson). 
  Neutrophils were identifi  ed by characteristic forward/side scatter and Gr-1 
positivity. Results were analyzed with FloJo software (Tree Star).
Immunofl  uorescent staining. Ankles harvested 7 d after serum transfer 
were cut in 5-μm frozen sections on a cryomicrotome support using a tape 
transfer method. After blocking, slides were stained with an Fc-specifi  c 
FITC-labeled F(ab′)2 fragment of goat anti–mouse IgG (Jackson Immuno-
Research Laboratories). Tissue sections were visualized using a fl  uorescent 
microscope, and digital photographs were processed using Adobe Photoshop 
(Adobe Systems).
Statistical analysis. Comparisons were analyzed for statistical signifi  cance 
by two-tailed Student’s t test using Microsoft Excel software, with P < 0.05 
considered signifi  cant.
Online supplemental material. Fig. S1 depicts representative fl  ow cy-
tometry of the bone marrow neutrophil population used for neutrophil 
adoptive transfer experiments. Fig. S2 depicts representative fl  ow cytometry 
of ankle synovial fl  uid from WT mice 20 h and 4 d after serum transfer. 
  Table S1 lists primers used for qPCR. The online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20052349/DC1.
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